Buffalo Biomedical technology Co., Ltd. was founded in 2020, and is specializing the development of novel therapy of acute lung disease and urine catheter disease. We are not only developing medical product, but also developing daily supplies, drug neutralization products and so on.
In 2024, we create "Bufflex" brand."Bufflex" is a emerging and interdisciplinary brand. "Bufflex" product is designed to address the long term care elder clean problem, and to address First responders and fire workers drug contact hazard. Therefore, we develop a series of deodorizing spray, dry bath agent, deodrize additive (need to be used with 75%ethanol and spray bottle) products, to solve long term care center smell, urine smell and body odor problems. And develop a drug neutralization spray products for reduced opioid epidemic contact hazard and keep First responders and fire workers safety. We are looking for interesting as our US agent to extended US market.
Bufflex will continue to develop new products to defend everyone’s health and safety.
Company Details
- Founded
- -
- Address
- 2f., No. 1, Sec. 5, Zhongxiao E. Rd., Xinyi Dist., Taipei City,taiwan 110,taiwan, Province Of China
- Industry
- Medical Device
- Website
- https://www.bufbio.com/
- HQ
- Taipei city, Taiwan
Buffalo Biomedical Technology Co., Ltd. Questions
Buffalo Biomedical Technology Co., Ltd.'s website is https://www.bufbio.com/
Buffalo Biomedical Technology Co., Ltd.'s LinkedIn profile is https://tw.linkedin.com/company/buffalobiotech
Buffalo Biomedical Technology Co., Ltd.'s industry is
Medical Device
Buffalo Biomedical Technology Co., Ltd.'s top competitors are
Tegmine Therapeutics, Inc.,
Obigen Pharma,
Nankang Biotech Incubation Center,
Pharmaessentia,
Obi Pharma,
Ap Biosciences, Inc..
Buffalo Biomedical Technology Co., Ltd.'s categories are Medical Device
Buffalo Biomedical Technology Co., Ltd.'s founding year is 2020
